权威 · 专业 · 易懂

您的血液健康专属指南

聚合全球前沿的血液病诊疗、研究和科普信息，为广大血液病患者、家属以及关注血液健康的人士提供权威、全面、易懂的一站式参考平台。

开始阅读常见问题

科普文章

血液病基础知识与健康科普

浏览文章

患者空间

关怀指导与康复经验分享

浏览文章

常见问题

血液病热门问题专业解答

查看FAQ

7+

专业文章

3

内容分类

10+

疾病话题

100%

免费阅读

最新文章

查看全部文章 »

血液病科普知识、最新研究进展与患者关怀

Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer database analysis

Blood Cancer Journal, Published online: 03 June 2026; doi:10.1038/s41408-026-01533-8Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer

Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with <i>NRAS</i> mutations to FLT3 inhibitors

Leukemia, Published online: 02 June 2026; doi:10.1038/s41375-026-02982-7Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibi

<i>TP53</i> deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome

Leukemia, Published online: 01 June 2026; doi:10.1038/s41375-026-02991-6TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome

Genetic and Clinical Features in TP53-Mutated Patients With Myelodysplastic Neoplasms: A Retrospective Study Based on Next-Generation Sequencing Data.

The recent fifth edition of World Health Organization and International Consensus Classification in 2022 recognized TP53-mutated myelodysplastic neoplasms (MDS) as a distinct entity requiring multi-hi

FAQ